IMTEC-MYOSITIS-LIA PL - COFEPRIS Registration 523R2018 SSA
Access comprehensive regulatory information for IMTEC-MYOSITIS-LIA PL (IMTEC-MYOSITIS-LIA PL) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 523R2018 SSA and manufactured by INVESTIGACIÓN DIAGNÓSTICA, S.A. DE C.V.. The device was registered on February 23, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL IMTEC-MYOSITIS-LIA PL ES UN INMUNOENSAYO ENZIMÁTICO INDIRECTO BASADO EN MEMBRANA PARA LA MEDICIÓN CUALITATIVA DE ANTICUERPOS DE CLASE IGG CONTRA JO-1, MI-2, PM-SCL, U1-SNRNP, KU, PL-7, PL-12 EN SUERO O PLASMA HUMANO. EL ENSAYO HA SIDO DISEÑADO PARA E
IMTEC-MYOSITIS-LIA PL IS A MEMBRANE-BASED INDIRECT ENZYME IMMUNOASSAY FOR THE QUALITATIVE MEASUREMENT OF IGG CLASS ANTIBODIES AGAINST JO-1, MI-2, PM-SCL, U1-SNRNP, KU, PL-7, PL-12 IN HUMAN SERUM OR PLASMA. THE ASSAY HAS BEEN DESIGNED TO